This is a routine distribution agreement termination. Monitor for any potential revenue impact from the brands after the transition period ends in September 2026, but no immediate trading action is warranted.
Price Chart
Executive Summary
Dr. Reddy's terminated a distribution and promotion agreement with Novartis India Limited (NIL) due to a change in NIL's controlling shareholding. The company will continue commercializing the affected brands until September 30, 2026. This is a routine operational update with no material financial impact disclosed.
Key Facts
- Terminated agreement dated February 11, 2022 with Novartis India Limited for distribution and promotion of select brands in India.
- Termination follows a change in controlling shareholding of Novartis India Limited.
- Dr. Reddy's will continue to commercialize the brands until September 30, 2026.
Financial Impact
No financial impact disclosed; immaterial to a $10.2B market cap company.
Risk Factors
- Potential loss of revenue from the brands after September 30, 2026, but likely immaterial given the company's size.
- No further details on the financial contribution of the terminated agreement provided.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (RDY) — Batch item 1 | 0001575872-26-000555 |
| Document: 0001575872-26-000555-index.html | 0001575872-26-000555 |
| Document: 0001575872-26-000555.txt | 0001575872-26-000555 |
| 6-K Filing (RDY) — Batch item 4 | 0001575872-26-000555 |
| Document: 0001575872-26-000555-index.html | 0001575872-26-000555 |
| Document: 0001575872-26-000555.txt | 0001575872-26-000555 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $11.91 $11.55 | ▼ −3.02% | ▼ −2.56% | $12.25 (+2.85%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Aug 26, 2026 5w ago | 6-K | $12.22 $12.16 | ▼ −0.49% | ▼ −1.15% | $12.25 (+0.25%) |
Aug 17, 2026 6w ago | 6-K | $12.11 $12.15 | ▲ +0.33% | ▲ +1.01% | $12.25 (+1.16%) |
Aug 13, 2026 7w ago | 6-K | $12.42 $12.27 | ▼ −1.21% | ▼ −1.01% | $12.25 (−1.37%) |
Aug 10, 2026 7w ago | 6-K | $12.15 $12.45 | ▲ +2.47% | ▲ +2.79% | $12.25 (+0.82%) |
Aug 3, 2026 8w ago | 6-K | $12.07 $12.10 | ▲ +0.25% | ▼ −1.55% | $12.25 (+1.49%) |
Jul 29, 2026 9w ago | 6-K | $11.76 $11.83 | ▲ +0.60% | ▼ −1.08% | $12.25 (+4.17%) |
Jul 23, 2026 10w ago | 6-K | $11.80 $11.79 | ▼ −0.08% | ▼ −0.19% | $12.25 (+3.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access